Publications & Posters
Scholary publications
Platform
July 2024
FASEB Science Research Conferences: TGFβ Superfamily
Structural characterization of selective inhibitors of TGFβ1 activation with differing mechanisms of action and clinical potential
Fibrosis
SRK-373
July 2024
Science Signaling
An antibody that inhibits TGFβ1 release from latent extracellular matrix complexes attenuates the progression of renal fibrosis
Cardiometabolic Disease
SRK-439
June 2024
American Diabetes Association Scientific Sessions
The Anti-Myostatin Antibody SRK-439 Promotes Healthy Body Composition in Combination with GLP-1RAs in a Mouse Model of Obesity
Spinal Muscular Atrophy
Apitegromab
June 2024
Cure SMA Annual Conference
An Update on Scholar Rock’s Progress in SMA
Immuno-Oncology
SRK-181
June 2024
American Society of Clinical Oncology
Phase1 study (DRAGON) of SRK-181 (linavonkibart), a latent TGFβ1 inhibitor, combined with pembrolizumab in anti-PD1 resistant patients with advanced solid tumors: Updated results of expansion phase
Spinal Muscular Atrophy
Apitegromab
March 2024
4th Scientific International Congress on SMA
